Sarilumab Dose Reduction to Manage Laboratory Abnormalities in an Open-Label Extension Study in RA Patients Burmester, G., Garg, A., van Hoogstraten, H., Graham, N., Boddy, A., Parrino, J., Genovese, M. C. WILEY-BLACKWELL. 2015

View details for Web of Science ID 000370860204313